Beyond Thailand: Making Sense of a Qualified AIDS Vaccine 'Success'

摘要

When researchers announced on 24 September that an AIDS vaccine trial had positive results for the first time in history, many wondered whether they were real. Some prominent skeptics remain, but that debate has largely given way to intense discussions about how to build on this surprising finding. "The results are conceptually a game changer," says AIDS vaccine researcher Gary Nabel, who heads the Vaccine Research Center at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), the main funder of the $105 million study.